{
  "trial_id": "NCT02238418",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age",
      "label": "met",
      "evidence": "between [18 mo et 18 yo["
    },
    {
      "criterion": "Chronic kidney disease",
      "label": "unknown"
    },
    {
      "criterion": "Renal transplant",
      "label": "unknown"
    },
    {
      "criterion": "Initial 25 OH vitamin D concentration < 75nmol/l",
      "label": "met",
      "evidence": "Vit D: 14ng/ml"
    },
    {
      "criterion": "Patient agree to participate (if old enough to give his agreement) and written informed consent signed by parents",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Contraindication to 100 000 IU Uvedose\u00ae treatment",
      "label": "triggers",
      "evidence": "known hypersensitivity to vitamin D or hypercalcemia, hypercalciuria or nephrolithiasis"
    },
    {
      "criterion": "Known hypersensitivity to vitamin D",
      "label": "unknown"
    }
  ],
  "notes": "Patient is a 34-year-old woman from Jordan with general and non-specific bones and joints pain. Her past medical history is unremarkable.",
  "_meta": {
    "topic_id": "53",
    "trial_id": "NCT02238418",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}